Scout Bio is a biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. The Company is advancing a number of programs across chronic kidney disease, chronic pain, and the inflammatory skin condition atopic dermatitis. Scout Bio's approach is to deliver a long-term expression of therapeutic proteins in pet patients using adeno-associated viral (AAV) vector technology, administered through a single intramuscular injection.
|HQ||Philadelphia, PA, US||Map|
|Employees (est.) (Apr 2019)||4|
Scout Bio total Funding
Scout Bio latest funding size
Time since last funding
|3 years ago|
Scout Bio investors
|Greenspring Associates, Correlation Ventures, RiverVest, Adage Capital Management, Frazier Healthcare Partners, Digitalis Ventures|
When was Scout Bio founded?
Scout Bio was founded in 2016.
Who are Scout Bio key executives?
Scout Bio's key executives are Mark Heffernan, Matt Wilson and Samantha Busfield.
How many employees does Scout Bio have?
Scout Bio has 4 employees.
Who are Scout Bio competitors?
Competitors of Scout Bio include Invetx, Merck Animal Health USA and Bioceltix.
Where is Scout Bio headquarters?
Scout Bio headquarters is located at 100 N 18th St #300, Philadelphia.
Where are Scout Bio offices?
Scout Bio has an office in Philadelphia.
How many offices does Scout Bio have?
Scout Bio has 1 office.
Receive alerts for 300+ data fields across thousands of companies